2023-2029 Global Bromhidrosis Disease Treatment Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Research, the global market for Bromhidrosis Disease Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Bromhidrosis Disease Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Bromhidrosis Disease Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Topical Antiseptic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Bromhidrosis Disease Treatment include AbbVie, Biovencer Healthcare, Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals, Ipsen Pharma, Johnson and Johnson, Journey Medical Corp and Medytox, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Bromhidrosis Disease Treatment. Report Highlights:
(1) Global Bromhidrosis Disease Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Bromhidrosis Disease Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Bromhidrosis Disease Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Bromhidrosis Disease Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Bromhidrosis Disease Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Bromhidrosis Disease Treatment, capacity, production and trends.
(7) Bromhidrosis Disease Treatment industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Topical Antiseptic
Antiperspirants
Botulinum Toxin
Market segment by application, can be divided into
Hospital
Drugs Store
Other
Market segment by players, this report covers
AbbVie
Biovencer Healthcare
Boehringer Ingelheim International GmbH
Galderma SA
Hikma Pharmaceuticals
Ipsen Pharma
Johnson and Johnson
Journey Medical Corp
Medytox
Merz Pharma GmbH and Co. KGaA
Novartis AG
Pfizer
1 Market Overview
1.1 Bromhidrosis Disease Treatment Definition
1.2 Global Bromhidrosis Disease Treatment Market Size and Forecast
1.2.1 By Revenue, Global Bromhidrosis Disease Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Bromhidrosis Disease Treatment Market Size, 2018-2029
1.2.3 Global Bromhidrosis Disease Treatment Price Trend, 2018-2029
1.3 China Bromhidrosis Disease Treatment Market Size and Forecast
1.3.1 By Revenue, China Bromhidrosis Disease Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Bromhidrosis Disease Treatment Market Size, 2018-2029
1.3.3 China Bromhidrosis Disease Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Bromhidrosis Disease Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Bromhidrosis Disease Treatment Share in Global Market, 2018-2029
1.4.3 Bromhidrosis Disease Treatment Market Size: China VS Global, 2018-2029
1.5 Bromhidrosis Disease Treatment Market Dynamics
1.5.1 Bromhidrosis Disease Treatment Market Drivers
1.5.2 Bromhidrosis Disease Treatment Market Restraints
1.5.3 Bromhidrosis Disease Treatment Industry Trends
1.5.4 Bromhidrosis Disease Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Bromhidrosis Disease Treatment Revenue by Company, 2018-2023
2.2 Global Bromhidrosis Disease Treatment Sales Volume by Company, 2018-2023
2.3 Global Bromhidrosis Disease Treatment Price by Company, 2018-2023
2.4 Global Bromhidrosis Disease Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Bromhidrosis Disease Treatment Concentration Ratio
2.6 Global Bromhidrosis Disease Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Bromhidrosis Disease Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Bromhidrosis Disease Treatment Revenue by Company, 2018-2023
3.2 China Bromhidrosis Disease Treatment Sales Volume by Company, 2018-2023
3.3 China Bromhidrosis Disease Treatment Bromhidrosis Disease Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Bromhidrosis Disease Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Bromhidrosis Disease Treatment Domestic VS Export
3.6 China Market, Bromhidrosis Disease Treatment Import & Export
3.6.1 China Market, Bromhidrosis Disease Treatment Import & Export, 2018-2029
3.6.2 China Bromhidrosis Disease Treatment Import & Export Trends
3.6.3 Main Sources of China Bromhidrosis Disease Treatment Import
3.6.4 Export Destination of China Bromhidrosis Disease Treatment
4 Bromhidrosis Disease Treatment Production by Region
4.1 Global Bromhidrosis Disease Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Bromhidrosis Disease Treatment Manufacturers
4.3 Global Major Manufacturers, Bromhidrosis Disease Treatment Capacity Expansion and Future Plans
4.4 Global Bromhidrosis Disease Treatment Capacity by Region
4.5 Global Bromhidrosis Disease Treatment Production by Region
4.5.1 Global Bromhidrosis Disease Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Bromhidrosis Disease Treatment Production by Region, 2018-2023
4.5.3 Global Bromhidrosis Disease Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Bromhidrosis Disease Treatment Industry Chain
5.2 Bromhidrosis Disease Treatment Upstream Analysis
5.2.1 Bromhidrosis Disease Treatment Core Raw Materials
5.2.2 Main Manufacturers of Bromhidrosis Disease Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Bromhidrosis Disease Treatment Production Mode
5.6 Bromhidrosis Disease Treatment Procurement Model
5.7 Bromhidrosis Disease Treatment Industry Sales Model and Sales Channels
5.7.1 Bromhidrosis Disease Treatment Sales Model
5.7.2 Bromhidrosis Disease Treatment Typical Distributors
6 Sights by Type
6.1 Bromhidrosis Disease Treatment Classification
6.1.1 Topical Antiseptic
6.1.2 Antiperspirants
6.1.3 Botulinum Toxin
6.2 By Type, Global Bromhidrosis Disease Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
6.4 By Type, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
6.5 By Type, Global Bromhidrosis Disease Treatment Price, 2018-2029
7 Sights by Application
7.1 Bromhidrosis Disease Treatment Segment by Application
7.1.1 Hospital
7.1.2 Drugs Store
7.1.3 Other
7.2 By Application, Global Bromhidrosis Disease Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
7.4 By Application, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
7.5 By Application, Global Bromhidrosis Disease Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Bromhidrosis Disease Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
8.3 By Region, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Bromhidrosis Disease Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Bromhidrosis Disease Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Bromhidrosis Disease Treatment Market Size Market Share
8.7 South America
8.7.1 South America Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Bromhidrosis Disease Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Bromhidrosis Disease Treatment Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
9.3 By Country, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Bromhidrosis Disease Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Bromhidrosis Disease Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Bromhidrosis Disease Treatment Market Size, 2018-2029
9.6.2 By Company, China Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Bromhidrosis Disease Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Bromhidrosis Disease Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Bromhidrosis Disease Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Bromhidrosis Disease Treatment Market Size, 2018-2029
9.10.2 By Company, India Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Bromhidrosis Disease Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbbVie
10.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position
10.1.2 AbbVie Bromhidrosis Disease Treatment Models, Specifications and Application
10.1.3 AbbVie Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbbVie Company Profile and Main Business
10.1.5 AbbVie Recent Developments
10.2 Biovencer Healthcare
10.2.1 Biovencer Healthcare Company Information, Head Office, Market Area and Industry Position
10.2.2 Biovencer Healthcare Bromhidrosis Disease Treatment Models, Specifications and Application
10.2.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Biovencer Healthcare Company Profile and Main Business
10.2.5 Biovencer Healthcare Recent Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.3.2 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Models, Specifications and Application
10.3.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.3.5 Boehringer Ingelheim International GmbH Recent Developments
10.4 Galderma SA
10.4.1 Galderma SA Company Information, Head Office, Market Area and Industry Position
10.4.2 Galderma SA Bromhidrosis Disease Treatment Models, Specifications and Application
10.4.3 Galderma SA Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Galderma SA Company Profile and Main Business
10.4.5 Galderma SA Recent Developments
10.5 Hikma Pharmaceuticals
10.5.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.5.2 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Models, Specifications and Application
10.5.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Hikma Pharmaceuticals Company Profile and Main Business
10.5.5 Hikma Pharmaceuticals Recent Developments
10.6 Ipsen Pharma
10.6.1 Ipsen Pharma Company Information, Head Office, Market Area and Industry Position
10.6.2 Ipsen Pharma Bromhidrosis Disease Treatment Models, Specifications and Application
10.6.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Ipsen Pharma Company Profile and Main Business
10.6.5 Ipsen Pharma Recent Developments
10.7 Johnson and Johnson
10.7.1 Johnson and Johnson Company Information, Head Office, Market Area and Industry Position
10.7.2 Johnson and Johnson Bromhidrosis Disease Treatment Models, Specifications and Application
10.7.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Johnson and Johnson Company Profile and Main Business
10.7.5 Johnson and Johnson Recent Developments
10.8 Journey Medical Corp
10.8.1 Journey Medical Corp Company Information, Head Office, Market Area and Industry Position
10.8.2 Journey Medical Corp Bromhidrosis Disease Treatment Models, Specifications and Application
10.8.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Journey Medical Corp Company Profile and Main Business
10.8.5 Journey Medical Corp Recent Developments
10.9 Medytox
10.9.1 Medytox Company Information, Head Office, Market Area and Industry Position
10.9.2 Medytox Bromhidrosis Disease Treatment Models, Specifications and Application
10.9.3 Medytox Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Medytox Company Profile and Main Business
10.9.5 Medytox Recent Developments
10.10 Merz Pharma GmbH and Co. KGaA
10.10.1 Merz Pharma GmbH and Co. KGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Models, Specifications and Application
10.10.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merz Pharma GmbH and Co. KGaA Company Profile and Main Business
10.10.5 Merz Pharma GmbH and Co. KGaA Recent Developments
10.11 Novartis AG
10.11.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.11.2 Novartis AG Bromhidrosis Disease Treatment Models, Specifications and Application
10.11.3 Novartis AG Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novartis AG Company Profile and Main Business
10.11.5 Novartis AG Recent Developments
10.12 Pfizer
10.12.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.12.2 Pfizer Bromhidrosis Disease Treatment Models, Specifications and Application
10.12.3 Pfizer Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Pfizer Company Profile and Main Business
10.12.5 Pfizer Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Research Methodology:
Global Bromhidrosis Disease Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|